T2	Pharmacological_substance 50 64	glycopyrrolate
N1000 	Reference T2 MeSH:D006024	glycopyrrolate
T3	Disorder 77 88	bradycardia
N1 	Reference T3 UMLS:C0428977	bradycardia
T4	Pharmacological_substance 115 130	dexmedetomidine
N1001 	Reference T4 MeSH:D020927	dexmedetomidine
T5	Pharmacological_substance 168 183	dexmedetomidine
N1002 	Reference T5 MeSH:D020927	dexmedetomidine
T6	Disorder 325 336	bradycardia
N2 	Reference T6 UMLS:C0428977	bradycardia
T8	Pharmacological_substance 532 547	dexmedetomidine
N1003 	Reference T8 MeSH:D020927	dexmedetomidine
T9	Disorder 556 567	bradycardia
N3 	Reference T9 UMLS:C0428977	bradycardia
T10	Pharmacological_substance 578 592	glycopyrrolate
N1004 	Reference T10 MeSH:D006024	glycopyrrolate
T12	Disorder 645 656	bradycardia
N4 	Reference T12 UMLS:C0428977	bradycardia
T15	Disorder 13 46	exaggerated hypertensive response
T16	Disorder 694 729	increase of arterial blood pressure
N5 	Reference T16 UMLS:C0006413	increase of arterial blood pressure
T20	Combination 568 572	with
T7	Subject 216 234	pediatric patients
T23	Disorder 203 211	sedation
N6 	Reference T23 UMLS:C0235195	sedation
T25	Manner_cue 682 693	exaggerated
